Theravance: BTIG Reiterates Buy Rating, PT Raised to $40

Tuesday, Feb 3, 2026 7:18 am ET1min read
TBPH--

Theravance: BTIG Reiterates Buy Rating, PT Raised to $40

Theravance: BTIG Reiterates Buy Rating, PT Raised to $40

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet